Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Gendron

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Investigation|October 31, 2023
Breast cancer immunopeptidomes contain numerous shared tumor antigensEralda Kina, Jean-Philippe Laverdure, Chantal Durette, et al.
Elife|April 18, 2024
Transposable elements regulate thymus development and functionJean-David Larouche, Céline M Laumont, Assya Trofimov, et al.
Blood|February 3, 2016
GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivoCaroline Pabst, Anne Bergeron, Vincent-Philippe Lavallée, et al.
Science Translational Medicine|December 7, 2018
Noncoding regions are the main source of targetable tumor-specific antigensCéline M Laumont, Krystel Vincent, Leslie Hesnard, et al.
Science (New York, N.Y.)|May 29, 2025
BRAF oncogenic mutants evade autoinhibition through a common mechanismHugo Lavoie, Ting Jin, Driss Lajoie, et al.
Nature|May 30, 2014
The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidationHiba Ahmad Zahreddine, Biljana Culjkovic-Kraljacic, Sarit Assouline, et al.
Genes, Chromosomes & Cancer|February 11, 2018
NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancyMathieu Roussy, Mélanie Bilodeau, Loubna Jouan, et al.
Blood|May 12, 2019
Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AMLSwati Garg, Armando Reyes-Palomares, Lixiazi He, et al.
Blood Advances|November 8, 2019
Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilitiesSophie Cardin, Mélanie Bilodeau, Mathieu Roussy, et al.
Blood Advances|November 3, 2021
Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemiaJana Krosl, Marie-Eve Bordeleau, Céline Moison, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Investigation|October 31, 2023
Breast cancer immunopeptidomes contain numerous shared tumor antigensEralda Kina, Jean-Philippe Laverdure, Chantal Durette, et al.
Elife|April 18, 2024
Transposable elements regulate thymus development and functionJean-David Larouche, Céline M Laumont, Assya Trofimov, et al.
Blood|February 3, 2016
GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivoCaroline Pabst, Anne Bergeron, Vincent-Philippe Lavallée, et al.
Science Translational Medicine|December 7, 2018
Noncoding regions are the main source of targetable tumor-specific antigensCéline M Laumont, Krystel Vincent, Leslie Hesnard, et al.
Science (New York, N.Y.)|May 29, 2025
BRAF oncogenic mutants evade autoinhibition through a common mechanismHugo Lavoie, Ting Jin, Driss Lajoie, et al.
Nature|May 30, 2014
The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidationHiba Ahmad Zahreddine, Biljana Culjkovic-Kraljacic, Sarit Assouline, et al.
Genes, Chromosomes & Cancer|February 11, 2018
NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancyMathieu Roussy, Mélanie Bilodeau, Loubna Jouan, et al.
Blood|May 12, 2019
Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AMLSwati Garg, Armando Reyes-Palomares, Lixiazi He, et al.
Blood Advances|November 8, 2019
Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilitiesSophie Cardin, Mélanie Bilodeau, Mathieu Roussy, et al.
Blood Advances|November 3, 2021
Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemiaJana Krosl, Marie-Eve Bordeleau, Céline Moison, et al.
Pageof 5